Ross Osborn
Stock Analyst at Cantor Fitzgerald
(0.54)
# 2529
Out of 5,370 analysts
118
Total ratings
27.00%
Success rate
-9.68%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
XGN Exagen | Maintains: Overweight | 8 7 | 7.52 | -6.91% | 6 | May 15, 2025 | |
LUCD Lucid Diagnostics | Reiterates: Overweight | 2 2 | 1.26 | 58.73% | 6 | May 15, 2025 | |
NPCE NeuroPace | Reiterates: Overweight | 17 17 | 11.07 | 53.57% | 6 | May 14, 2025 | |
SIBN SI-BONE | Reiterates: Overweight | 25 25 | 17.91 | 39.59% | 9 | May 6, 2025 | |
NNOX Nano X Imaging | Maintains: Overweight | 12 9 | 5.25 | 71.43% | 11 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 46 46 | 28.56 | 61.06% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 8 | 1.76 | 354.55% | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 24 24 | 9.74 | 146.41% | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 13 | 5.98 | 117.39% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 4 4 | 1.41 | 183.69% | 4 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 9 9 | 7.09 | 26.94% | 7 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 9 | 4.04 | 122.77% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 21 21 | 5.46 | 284.62% | 10 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 16 | 7.74 | 106.72% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 14 | 5.87 | 138.5% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 96 | 81.86 | 17.27% | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 4 4 | 1.38 | 153.62% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 3 3 | 0.72 | 247.22% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 7 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 4 4 | n/a | n/a | 5 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 3.25 | 53.85% | 2 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 9 | 0.63 | 1266.67% | 2 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 27 21 | n/a | n/a | 2 | Apr 22, 2022 |